The drug maker said on Tuesday it is “firmly committed to investing and growing in the US” despite President Donald Trump threatening to apply import taxes on the sector.
“Additionally, we have even greater US investment in manufacturing and R&D (research and development) planned,” he added.
Industry experts have suggested that the new tariffs might be 25 per cent, which would match those levied on steel, aluminium and cars.
Meanwhile, the group reported a 10 per cent increase in revenue for the first three months of 2025, compared with the same period last year.
The company is planning to hit US$80 billion in annual revenue by 2030, which Soriot said it is making “excellent progress” towards.
Last year’s revenue was US$54.1 billion.
Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca eyes US expansion despite Trump tariff threat )
Also on site :